Reported about 16 hours ago
Institutional Shareholder Services (ISS) has advised investors to oppose the $9 billion acquisition of Core Scientific by CoreWeave, citing Core Scientific's successful performance as an independent entity. With a scheduled vote on October 30, concerns were raised regarding the deal's structure and valuation, especially as CoreWeave's stock value has declined. Following the advisory, Core Scientific's stock rose over 5%, indicating a preference for independence among investors.
Source: YAHOO